Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

anidulafungin

anidulafungin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Eraxis POWDER FOR INJECTION, INTRAVENOUS 50 mg, 100 mg    


Comments:

ORDER FORMULATION

THERAPEUTIC INTERCHANGE

anidulafungin (Eraxis)

  • (Esophageal Candidiasis) 100mg Loading Dose, then 50mg daily
  • (Candidemia, candidiasis, and other candida infections) 200mg Loading Dose, then 100mg daily

micafungin (Mycamine)

  • 150 mg daily                                                                                
  • 100 mg daily

Echinocandin Criteria For Use


Reviewed: January 26, 2010


Last updated: Dec. 19, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.